A stent with radioactive seed strand insertion for inoperable malignant biliary obstruction: A meta-analysis

Huang, Yiyang; Xu, Xinyan; Huang, Xiaochao; Cheng, Hong

doi:10.1016/j.brachy.2021.01.010

Cited by 7 publications

(11 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The post-stenting biliary drainage may decrease the early complication rate [8]. Stent re-obstruction and patency duration are the core endpoints of the studies regarding of the stent insertion [27][28][29][30]. In this meta-analysis, SBS bilateral stenting showed a significantly lower re-obstruction rate with longer stent patency duration when compared to SIS bilateral stenting.…”

Section: Discussionmentioning

confidence: 97%

Side-by-side versus stent-in-stent bilateral stenting for malignant hilar biliary obstruction: a meta-analysis.

Chen¹,

Gao²,

Li³

et al. 2022

Videosurgery and Other Miniinvasive Techniques

View full text Add to dashboard Cite

Introduction: Both side-by-side (SBS) and stent-in-stent (SIS) bilateral stenting have been used for patients with malignant hilar biliary obstruction (MHBO). However, it is unclear which technique is better. Aim: This meta-analysis is conducted to investigate the clinical efficacy and safety of SBS and SIS bilateral stenting for patients with MHBO. Material and methods: Relevant studies were searched in PubMed, Embase, Cochrane Library, Wanfang, VIP, and CINK databases. The timeline for the searches was from the establishment of the database to September 2021. The relative outcomes are pooled. Results: A total of 7 studies fulfilled the inclusion criteria and entered into this meta-analysis. The pooled technical success rate was significant higher in the SIS group than that in the SBS group (p = 0.04). The pooled early complication rate was significantly lower in the SIS group than in the SBS group (p = 0.04). The pooled stent re-obstruction rate was significantly lower in the SBS group than in the SIS group (p = 0.04). The pooled stent patency duration was significantly longer in the SBS group than in the SIS group (p = 0.01). The pooled functional success rates (p = 0.79), total complication rates (p = 0.34), and overall survival duration (p = 0.27) were comparable between 2 groups. Egger test did not show any publication bias. Conclusions: When comparing the SBS and SIS bilateral stenting for patients with MHBO, although SIS technique may have the superiorities of technical success and early complication rates, the longer stent patency was achieved by the SBS technique.

show abstract

Section: Discussionmentioning

confidence: 97%

Side-by-side versus stent-in-stent bilateral stenting for malignant hilar biliary obstruction: a meta-analysis.

Chen¹,

Gao²,

Li³

et al. 2022

Videosurgery and Other Miniinvasive Techniques

View full text Add to dashboard Cite

show abstract

“…Radiation using 192 Ir high dose rate (HDR) intraluminal brachytherapy (HDR ILBT) delivered after endoscopic placement of a catheter at the site of obstruction can also be used. Studies evaluating the efficacy of HDR ILBT demonstrate longer stent patency and improved overall survival (OS) compared with stent alone 14–17. External beam RT following stent placement can improve stent patency compared with stent alone,18 and retrospective data suggest that this approach results in improved local control and OS 19…”

Section: Methodsmentioning

confidence: 99%

“…Studies evaluating the efficacy of HDR ILBT demonstrate longer stent patency and improved overall survival (OS) compared with stent alone. [14][15][16][17] External beam RT following stent placement can improve stent patency compared with stent alone, 18 and retrospective data suggest that this approach results in improved local control and OS. 19 Photodynamic therapy (PDT), using light activation during endoscopy, or intraluminal radiofrequency ablation (RFA), has also been used alone or in combination with other therapies to treat the tumor and increase stent patency duration.…”

Section: Management Of Malignant Biliary Obstruction (Mbo)mentioning

confidence: 99%

American Radium Society (ARS) Appropriate Use Criteria (AUC) for Extrahepatic Cholangiocarcinoma

Tchelebi¹,

Jethwa

Levy³

et al. 2022

American Journal of Clinical Oncology

View full text Add to dashboard Cite

Although uncommon, extrahepatic cholangiocarcinoma (EHCC) is a deadly malignancy, and the treatment approaches remain controversial. While surgery remains the only cure, few patients are candidates for resection up front, and there are high rates of both local and distant failure following resection. Herein, we systematically review the available evidence regarding treatment approaches for patients with EHCC, including surgery, radiation, and chemotherapy. The evidence regarding treatment outcomes was assessed using the Population, Intervention, Comparator, Outcome, and Study design (PICOS) framework. A summary of recommendations based on the available literature is outlined for specific clinical scenarios encountered by providers in the clinic to guide the management of these patients.

show abstract

“…In our meta-analysis, we included 7 RCTs and 11 retrospective studies. Compared with a previous meta-analysis [19,44], we provided relatively useful evidence. In addition, we conducted subgroup analysis between two different types of I-125 delivery with metal stents, which may provide a more individual option to treat MBO by I-125 seeds.…”

Section: Strengths and Limitationmentioning

confidence: 99%

Outcomes of two types of iodine-125 seeds delivery with metal stents for malignant biliary obstruction: a systematic review and meta-analysis

Fu¹,

Han²,

Qiu³

et al. 2023

Diagn Interv Radiol

View full text Add to dashboard Cite

show abstract

A stent with radioactive seed strand insertion for inoperable malignant biliary obstruction: A meta-analysis

Cited by 7 publications

References 22 publications

Side-by-side versus stent-in-stent bilateral stenting for malignant hilar biliary obstruction: a meta-analysis.

Side-by-side versus stent-in-stent bilateral stenting for malignant hilar biliary obstruction: a meta-analysis.

American Radium Society (ARS) Appropriate Use Criteria (AUC) for Extrahepatic Cholangiocarcinoma

Outcomes of two types of iodine-125 seeds delivery with metal stents for malignant biliary obstruction: a systematic review and meta-analysis

Contact Info

Product

Resources

About